Material for removing beta-2 microglobulin from blood
Abstract
A material for removing beta-2 microglobulin from blood by passing the blood through the material which are hydrophilic and biocompatible a size and a structure selected so as to remove beta-2 microglobulin from the blood, wherein said material is a porous beaded polydivinylbenzene or polystyrene-co-polydivinylbenzene polymer with a surface of [the] beads and of pores modified so as to prevent adsorption of large proteins and platelets and to minimize activation of blood complement system without affecting noticeably accessibility of an inner absorption space of the beads for beta-2 microglobulin and middle-sized toxicant molecules, in which polymer surface exposed vinyl groups are chemically modified so as to form different surface exposed functional groups which are hydrophilic and biocompatible.
Claims
exact text as granted — not AI-modified1 . A material for removing beta-2 microglobulin from blood by passing the blood through the material which are hydrophilic and biocompatible a size and a structure selected so as to remove beta-2 microglobulin from the blood, wherein said material is a porous beaded polydivinylbenzene or polystyrene-co-polydivinylbenzene polymer with a surface of beads and of pores modified so as to prevent adsorption of large proteins and platelets and to minimize activation of blood complement system without affecting noticeably accessibility of an inner absorption space of the beads for beta-2 microglobulin and middle-sized toxicant molecules, in which polymer surface exposed vinyl groups are chemically modified so as to form different surface exposed functional groups which are hydrophilic and biocompatible.
2 . A material for removing beta-2 microglobulin from blood as defined in claim 1 , wherein the beads contain more than 50% of divinylenzene.
3 . A material for removing beta-2 microglobulin from blood as defined in claim 1 , wherein the beads contain more than 60% of divinylenzene.
4 . A material for removing beta-2 microglobulin from blood as defined in claim 1 , wherein the beads contain more than 75% of divinylenzene.
5 . A material for removing beta-2 microglobulin from blood as defined in claim 1 , wherein the beads contain 55% of divinylenzene.
6 . A material for removing beta-2 microglobulin from blood as defined in claim 1 , wherein the beads contain 65% of divinylenzene.
7 . A material for removing beta-2 microglobulin from blood as defined in claim 1 , wherein the beads contain 80% of divinylenzene.Join the waitlist — get patent alerts
Track US2002143283A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.